Intel Corp’s Senti Biosciences Holdings SNTI Stock Holding History

Intel Corp’s Portfolio SNTI Stock Details SNTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-48,048	Closed	-$109K	–	3
2024 Q3	$109K	Sell	48,048 -11,519	-19%	-$30.4K	0.04%	3
2024 Q2	$164K	Hold	59,567	–	–	0.03%	4
2024 Q1	$225K	Hold	59,567	–	–	0.03%	6
2023 Q4	$393K	Hold	59,567	–	–	0.13%	6
2023 Q3	$246K	Hold	59,567	–	–	0.08%	6
2023 Q2	$373K	Hold	59,567	–	–	0.1%	7
2023 Q1	$703K	Hold	59,567	–	–	0.35%	7
2022 Q4	$840K	Hold	59,567	–	–	0.4%	7
2022 Q3	$1.29M	Hold	59,567	–	–	0.52%	5
2022 Q2	$1.17M	Buy	+59,567	New	+$4.78M	0.47%	4

Other funds holding SNTI

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

8GI

8VC GP I Austin, Texas $39.6M AUM 36.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Intel Corp's SNTI Position: Q4 2024 in Review

Intel Corp sold out of Senti Biosciences Holdings (SNTI) in Q4 2024, closing a stake of 48,048 shares — an estimated $109K sold.

Intel Corp first reported a position in SNTI in Q2 2022 and held it in 10 quarters. The position peaked at $1.29M in Q3 2022. 16 funds tracked by Wall St. Rank hold SNTI as of Q4 2024.

Intel Corp reported no remaining Senti Biosciences Holdings position as of Q4 2024 after selling out during the quarter.
Intel Corp sold 48,048 Senti Biosciences Holdings shares in Q4 2024, an estimated $109K.
Intel Corp first reported a position in Senti Biosciences Holdings in Q2 2022 and held it in 10 quarters.
Intel Corp's Senti Biosciences Holdings position peaked at $1.29M in Q3 2022.
16 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q4 2024.

Based on Intel Corp's 13F filing for Q4 2024, filed 13 Feb 2025.